Kafa a 2009, JYMed ne a Pharmaceutical sha'anin a kasar Sin cewa integrates R & D, masana'antu, kasuwanci, da al'ada ci gaba da kuma masana'antu na peptide kayayyakin. Kamfanin yana da kusan ma'aikata 570, tare da ƙungiyar gudanarwa ta asali wanda ya ƙunshi ƙwararrun ƙwararrun magunguna da fiye da shekaru 20 na gogewa a cikin masana'antar peptide. JYMed yana aiki da cibiyar bincike guda ɗaya da manyan wuraren samarwa guda biyu, yana samun damar samar da sikelin da yawa a cikin peptides, yana sanya shi a matsayin jagoran masana'antu.
JYMed yana ba da fayil iri-iri na peptide APIs, gami da sama da nau'ikan 20 kamar Semaglutide, Tirzepatide, Liraglutide, Degarelix, da Oxytocin. Daga cikin waɗannan, samfurori guda biyar, ciki har da Semaglutide da Tirzepatide, sun sami nasarar kammala rajista na FDA Drug Master File (DMF).
JYMed yana ba da peptides na kwaskwarima masu inganci, albarkatun ƙasa, da sabis na ƙirƙira OEM daga darajar bincike zuwa darajar cGMP, duk tare da ingantaccen iko mai inganci. Our roba peptides, sananne ga su aminci da sauƙi na gyare-gyare, su ne muhimman sinadaran a cikin kwaskwarima masana'antu, isar da tabbatattun amfani ga gashi kula, rauni warkar, anti-tsufa, anti-alama, whitening, da gashin ido girma.
JYMed yana da ingantaccen tsarin masana'antar peptide mai inganci, yana ba abokan ciniki cikakken sabis na peptide da samfuran analog na peptide, gami da bincike da samar da peptides na warkewa, peptides na dabbobi, peptides na kwaskwarima, da RNA, tare da tallafi don rajista da bin ka'ida. .
A matsayin abokin ciniki-daidaitacce sha'anin, JYMed yana da wani m peptide masana'antu tsarin, tare da fiye da 20 shekaru gwaninta a peptide R&D da kuma na-da-art wurare. Muna ba da cikakken kewayon high quality peptides dangane da abokin ciniki ta bukatar: Yawan daga MG zuwa kg, da tsarki daga danye zuwa> 99%, daga wadanda ba GMP zuwa GMP sa, daga sauki peptides zuwa modified peptides, antigenic peptides ci gaba, akwai yarjejeniyar sirri.
Gabatarwar JYMed, mai kera peptide na Amurka FDA ta bincika. Abubuwan da aka nuna: peptides na kwaskwarima, peptide APIs, peptides na al'ada, irin su, Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8, da dai sauransu Don ƙarin sani, tuntuɓi.
Email: jymed@jymedtech.com
Kwanan nan, wurin samar da peptide na JYMed, Hubei Jianxiang Biopharmaceutical Co., Ltd., ya karɓi takaddun hukuma guda biyu da Hukumar Kula da Magunguna ta Lardin Hubei ta bayar: “Sakamakon Sakamako na Kula da Magungunan GMP” (No. E GMP 2024-258 da No. E GMP) 2024-260) a...
Daga 26 ga Agusta zuwa 30 ga Agusta, 2024, wurin samar da peptide na JYMed, Hubei JX Bio-Pharmaceutical Co., Ltd., ya yi nasarar shawo kan wani binciken da Hukumar Abinci da Magunguna ta Amurka (FDA) ta gudanar. Binciken ya kunshi muhimman wurare...
01. Baje kolin Baje kolin A ranar 8 ga Oktoba, 2024 CPHI Worldwide Pharmaceutical Exhibition ya fara a Milan. A matsayin daya daga cikin muhimman abubuwan da suka faru na shekara-shekara a masana'antar harhada magunguna ta duniya, ya jawo mahalarta daga kasashe da yankuna 166. Da over...